Solving the Problem of Organ Donation Shortage by Hodge, Samuel D., Jr. & Saitta-Gill, Nicole Marie
University of Baltimore Law Review
Volume 45
Issue 1 Fall 2015 Article 3
2015
Solving the Problem of Organ Donation Shortage
Samuel D. Hodge Jr.
Temple University, shodge@temple.edu
Nicole Marie Saitta-Gill
Stradley Ronon Stevens & Young, LLP, ngill@stradley.com
Follow this and additional works at: http://scholarworks.law.ubalt.edu/ublr
Part of the Medical Jurisprudence Commons
This Article is brought to you for free and open access by ScholarWorks@University of Baltimore School of Law. It has been accepted for inclusion in
University of Baltimore Law Review by an authorized administrator of ScholarWorks@University of Baltimore School of Law. For more information,
please contact snolan@ubalt.edu.
Recommended Citation
Hodge, Samuel D. Jr. and Saitta-Gill, Nicole Marie (2015) "Solving the Problem of Organ Donation Shortage," University of Baltimore





SOLVING THE PROBLEM OF ORGAN DONATION 
SHORTAGE 
Nicole Saitta-Gill and Samuel D. Hodge, Jr.
* 
ABSTRACT 
Organ donation, a medically perfected procedure, affords a second 
chance at life for many people.  Unfortunately, organ transplantation 
demonstrates the stark reality of supply and demand.  Thousands of 
individuals are added to the transplant list each day, but many more 
die during the same time frame waiting for new organs.1  The 
solution to this dilemma seems simple: increase the supply.  This 
article will discuss several ways to achieve this goal.  First, through 
the HIV Organ Policy Equity Act, which allows for HIV-positive-to-
HIV-positive transplants,2 more transplantable organs will hopefully 
be available in the future.  Second, the supply of organs may increase 
by changing the standards of organ donation from irreversible loss of 
brain function to irreversible loss of cardiac function.3  Third, 
educating individuals, especially minorities, about donation and the 
regionally based system for transplants may result in a larger number 
of matching donors and a greater number of potential recipients on 
multiple transplant lists.  Finally, efforts such as payments and 
advertising for organs, giving priority transplants to registered 
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1. U.S. Dep’t of Health and Human Servs., The Need Is Real: Data, ORGANDONOR.GOV, 
http://www.organdonor.gov/about/data.html (last visited Nov. 13, 2015).  
 2. 42 U.S.C. § 274 (2012). 
 3. Jane Brody, The Solvable Problem of Organ Shortages, N.Y. TIMES (Aug. 28, 2007), 
http://www.nytimes.com/2007/08/28/health/28brod.html?_r=1&.   
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donors, and even confronting the disparate number of elderly donors 
whose organs are never transplanted, may result in an increase in the 
organ supply. 
INTRODUCTION 
Organ donation4 affords a second chance at life for many people.5  
It is also one of the most extraordinary gifts a human can give 
another since it can literally mean the difference between life and 
death.  Unfortunately, organ transplantation classically demonstrates 
the stark reality of supply and demand.6  Thousands of individuals are 
added to the transplant list each year,7 and on average, twenty-two 
 
 4. Organ donation is defined as “the surgical process of providing one or more organs to 
be used for transplantation into another person.  Organ donors can be deceased or 
living.”  U.S. Dep’t of Health and Human Servs., Organ Donation and 
Transplantation Saves Lives, ORGANDONOR.GOV, http://www.organdonor.gov/about/in
dex.html (last visited Nov. 13, 2015).  A brief legal history of organ donation is as 
follows: The National Conference of Commissioners of Uniform Acts (NCCUA) 
“issued the Uniform Anatomical Gift Act (UAGA) in 1968, which was adopted . . . by 
all fifty states.”  Brendan Abel, Physician Assisted Homicide in Organ Donations 
After Cardiac Death: The Failure of Biotechnologies to Comply with the Uniform 
Definition of Death Act and the Dead Donor Rule, 7 J. HEALTH & BIOMEDICAL L. 573, 
581 (2012) (internal quotation marks omitted).  Congress passed two additional acts in 
the 1980s.  The National Organ Transplant Act (NOTA) of 1984 “prohibited the sale 
of organs and tissues and ordered the Department of Health and Human Services 
(DOHHS) to establish the Organ Procurement Transplant Network (OPTN) . . . for 
organ matching.”  Id. at 588 (internal quotation marks omitted).  “The NCCUA [also] 
revised the UAGA in 1987; however, only twenty-one states adopted the revision. . . .  
Both iterations of the UAGA adopt the opt-in theory for solid organ donations . . . .”  
Id. at 582.  Adding Section Four to the 1987 UAGA “authorized coroners, medical 
examiners, and public health officials to remove designated body parts, such as 
corneas, without consent for transplantation if several conditions were met.”  Id. 
 5. U.S. Dep’t of Health and Human Servs., Becoming a Donor, ORGANDONOR.GOV, 
http://www.organdonor.gov/becomingdonor/index.html?gclid=CIav9JukvsMCFUkvg
QodI1gAyQ (last visited Nov. 13, 2015).  The concept of organ transplantation is not 
new to medicine.  History shows that in the third century A.D., a physician in China 
discussed organ transplants.  Medicine has now progressed beyond the days of mere 
conceptualization of the process to the point where organ transplantation is an 
ordinary medical procedure.  In addition to organs, such as livers and hearts, doctors 
have transplanted hands and even a face.  See Robert John Kane & Lawrence E. 
Singer, Organ and Tissue Transplantation-Anatomical Gifts, 22 ILL. PRAC., THE LAW 
OF MEDICAL PRACTICE IN ILLINOIS § 33:1 (3d ed.). 
 6. Melissa Wong, Coverage for Kidneys: The Intersection of Insurance and Organ 
Transplantation, 16 CONN. INS. L.J. 535, 535 (2010). 
 7. See Data, UNITED NETWORK FOR ORGAN SHARING, https://www.unos.org/data/ (last 
visited Nov. 13, 2015).  As of 9:37 AM on September 14, 2015, 122,532 individuals 
were on the list for a transplant.  While 15,083 transplants occurred between January 
and June of 2015, these organs came from only 7323 donors.  Id.  
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people die every twenty-four hours waiting for new organs.8  The 
easiest way to solve the problem of transplant shortages seems 
simple: increase the supply.9  But how can this seemingly simple goal 
be achieved?  First, through the HIV Organ Policy Equity Act, which 
allows for HIV-positive-to-HIV-positive transplants, more 
transplantable organs will hopefully be available in the future.10  
Second, the supply of organs may increase by changing the standards 
of organ donation from irreversible loss of brain function to 
irreversible loss of cardiac function.11  Educating individuals, 
especially minorities, about donation and the regionally based system 
for transplants may result in a larger number of matching donors and 
a greater number of potential recipients on multiple transplant lists.12  
And other suggestions, such as payments and advertising for organs, 
giving priority transplants to registered donors, and even confronting 
 
 8. U.S. Dep’t of Health and Human Servs., supra note 1. 
 9. Transplants are relatively routine in medical practice and the success rate is fairly 
high.  Nevertheless, it is not without risk and some of the major dangers include: “1) 
blood and tissue incompatibility between the patient and the donor; 2) ineffective 
treatment to restrict the patient’s own immune system from ‘attacking’ the 
transplanted organ; and 3) deterioration of the organ caused by a lack of oxygenated 
blood, known as ischemia.”  Abel, supra note 4, at 575. 
 10. A major issue in transplants is the cost and whether health insurance will pay for it. 
Congress has attempted to regulate this problem under Medicaid by making sure 
states apply their coverage decisions in a uniform and fair fashion.  As noted in Ellis 
v. Paterson:   
To assure that State coverage decisions for organ transplants are 
based on clear principles consistently applied, and not on political 
or media considerations, section 9507 of the Consolidated 
Omnibus Budget Reconciliation Act of 1985 (COBRA), P.L. 99-
272, requires that a State which covers organ transplant 
procedures set forth under its Medicaid plan written standards 
respecting the coverage of such procedures. Under these 
standards, similarly situated individuals must be treated alike.   
 Ellis v. Patterson, 859 F.2d 52, 55 (8th Cir. 1988) (emphasis omitted) (quoting H.R. 
Rep. No. 100-391, pt. 1, at 532 (1987), reprinted in 1987 U.S.C.C.A.N. 2313-1, 2313-
352).  Nevertheless, while Congress may establish guidelines and standards to 
guarantee state obedience with the Medicaid laws, it is still the obligation of the states 
to create coverage criteria “subject to federal approval and reimbursement.”  Wong, 
supra note 6, at 546. 
 11. See Maxine M. Harrington, The Thin Flat Line: Redefining Who Is Legally Dead in 
Organ Donation After Cardiac Death, 86 DENV. U. L. REV. 335, 337 (2009) 
(explaining the benefits of donations after “cardiac death” rather than “brain death”).  
 12. Kimberly D. Krawiec & Michael A. Rees, Reverse Transplant Tourism, 77 L. & 
CONTEMP. PROBS. 145, 172 (2014); see also Ingrid Kinkopf-Zajac, Assessing Patient 
Compliance in the Selection of Organ Transplant Recipients, 6 HEALTH MATRIX 503, 
503 (1996). 
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the disparate number of elderly donors whose organs are never 
transplanted, may result in an increase in the organ supply.13 
I. INCREASING THE SUPPLY THROUGH HIV-POSITIVE 
TRANSPLANTS 
Many HIV-positive patients are on a transplant waiting list, waiting 
for a kidney or liver.14  What if the wait is too long?  What if the 
person dies before receiving the life-saving organ?  Would you be 
appalled if you discovered that a matching donor kidney could have 
been transplanted, but it was discarded after testing positive for 
HIV?15  This scenario is more real than you think.  For many years, 
HIV patients were banned from donating organs because of the 
uncertainty as to what caused the disease.16  Fortunately, with the 
signing of the HIV Organ Policy Equity Act, HIV-positive 
individuals can now obtain transplants from HIV-positive donors.17 
 
 13. See generally Paul P. Lee, The Organ Supply Dilemma: Acute Responses to a Chronic 
Shortage, 20 COLUM. J.L. & SOC. PROBS. 363 (1986) (discussing the possible increase 
in available donative organs through payment and priority systems). 
 14. Many HIV-positive individuals suffer from kidney and renal disease.  Michele 
Roland, Safety and Efficacy of Solid Organ Transplantation in HIV-Positive Patients, 
PHYSICIANS’ RES. NETWORK (2001), http://www.prn.org/images/pdfs/503_roland_v6n
1.pdf.   
 15. There are a variety of laws that require donors to be tested for HIV prior to the 
transplantation of their organs.  However, Montana takes an interesting approach and 
will allow a transplant without HIV testing in an emergency.  Its law states:  
Prior to donation of an organ, semen, or tissues, HIV diagnostic 
testing of a prospective donor, in accordance with nationally 
accepted standards adopted by the department by rule, is required 
unless the transplantation of an indispensable organ is necessary 
to save a patient’s life and there is not sufficient time to perform 
an HIV diagnostic test.  
 MONT. CODE ANN. § 50-16-1008(1) (2013); accord 20 ILL. COMP. STAT. ANN. 
2310/2310–330 (West 2007). 
 16. Could HIV-Infected Organs Save Lives?, JOHNS HOPKINS MED. (Mar. 30, 2011), 
http://www.hopkinsmedicine.org/news/media/releases/could_hiv_infected_organs_sa
ve_lives.  
 17. Such a transplant would clearly have to come with a full disclosure of the fact that the 
organ is coming from a person infected with HIV to avoid a malpractice claim.  For 
instance, in a case in which the names of the parties have been withheld, the decedent 
obtained a kidney from a donor with brain cancer.  While this type of transplant is 
allowed, the decedent also developed a malignant glioblastoma.  In a malpractice suit 
against the transplant surgeon, it was alleged that the decedent should have been told 
that the transplanted organ was donated by a person with cancer.  The case was settled 
for $750,000.  24 NEW ENG. JURY VERDICT REV. & ANALYSIS, 2007, at 1:C3, 2007 
WL 8026533 (Mass.); cf. Kelly v. Fenton, No. 08-33833, 2012 WL 1359760, slip op. 
30878(U) (N.Y. Sup. Ct. Mar. 30, 2012). 
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A. A Background on HIV: How It Is Different From AIDS  
The Center for Disease Control (CDC) estimates that over 1.2 
million people aged thirteen years and older are living with HIV, 
including over 156,300 who are unaware they are affected.18  About 
50,000 people become infected with HIV each year, and in 2010, 
there were around 47,500 new HIV infections in the United States 
alone.19  In 2013, the estimated number of persons diagnosed with 
AIDS in the United States was 26,6888.20  But, while the acronyms 
“AIDS” and “HIV” are commonplace in today’s jargon, many 
individuals remain unaware of the difference between the two terms 
or do not fully understand what they mean.   
HIV stands for “Human Immunodeficiency Virus” and is similar to 
other pervasive viruses, such as the flu.21  However, while the body 
uses its immune system to rid itself of the flu, it cannot rid itself of 
HIV.22  In fact, HIV attacks key cells that are part of the immune 
system, using them to multiply before destroying them.23  When the 
body can no longer fight infections and disease because of a 
depletion of immune system cells, the final stage of the HIV 
infection, known as AIDS, occurs.24   
AIDS stands for “Acquired Immune Deficiency Syndrome,” and a 
person is characterized as having AIDS once he has “less than 200 
CD4 cells” (also known as “T-helper” cells which are a critical part 
of one’s immune system) “or if [his] CD4 percentage is less than 
14% percent.”25  A patient is also diagnosed as having AIDS when he 
develops an opportunistic infection, such as pneumonia, skin cancer, 
a particular eye infection, or a fungal infection that can cause 
thrush.26  Globally, in 2014, 1.2 million people died of AIDS-related 
 
 18. HIV in the United States: At a Glance, CTRS. FOR DISEASE CONTROL & PREVENTION, 
http://www.cdc.gov/hiv/statistics/basics/ataglance.html (last updated July 1, 2015).  
 19. Basic Statistics, CTRS. FOR DISEASE CONTROL & PREVENTION, 
http://www.cdc.gov/hiv/basics/statistics.html (last updated Sept. 29, 2015). 
 20. Statistics Overview, CTRS. FOR DISEASE CONTROL & PREVENTION, 
http://www.cdc.gov/hiv/statistics/basics/ (last updated Sept. 11, 2015). 
 21. What is HIV/AIDS?, AIDS.GOV, https://www.aids.gov/hiv-aids-basics/hiv-aids-
101/what-is-hiv-aids/ (last updated Apr. 29, 2014). 
 22. Id. 
 23. Id. 
 24. Id. 
 25. Int’l Assoc. of Providers of AIDS Care, What Is AIDS?, AIDS INFONET (Jan. 24, 
2014), http://www.aidsinfonet.org/uploaded/factsheets/180_eng_101.pdf. 
 26. Id. 
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causes.27  It is important to note, however, that “not everyone who has 
HIV progresses to AIDS,” and, especially with advances in treatment, 
individuals infected with HIV “can have a nearly normal life 
expectancy.”28  It is this population, those living with HIV that has 
not progressed to AIDS, that the HIV Organ Policy Equity Act 
targets. 
B. History Surrounding Positive-Positive Transplants 
The HIV Organ Policy Equity (HOPE) Act, signed in November 
2013, updates regulations that were well out of date.29  The National 
Organ Transplant Act, enacted in 1984, and a particular 1988 
amendment to this Act, prohibited donations of HIV-infected 
organs.30  This ban was enacted around the same time as bans 
prohibiting people with HIV from donating blood and stemmed from 
a belief that “organs should go to people with a better chance of 
survival.”31  Thus, attitudes surrounding the 1988 amendment 
reflected the pervasive bias against HIV-infected patients, whether 
they be donors or recipients.32   
In 1994, the CDC’s “Guidelines for Preventing Transmission of 
Human Immunodeficiency Virus [HIV] Through Transplantation of 
Human Tissue and Organs” provided that “[r]egardless of their HIV 
antibody test results,33 persons who meet any of the criteria listed 
 
 27. HIV/AIDS, WORLD HEALTH ORG., http://www.who.int/features/qa/71/en/ (last updated 
July 2015). 
 28. What Is HIV/AIDS?, supra note 21.  
 29. Brian Krans, HIV Organ Donation Gives Hope to Thousands of Patients, 
HEALTHLINENEWS (Dec. 1, 2013), http://www.healthline.com/health-news/hiv-organ-
donation-will-save-thousands-of-lives-120113. 
 30. Id.  
 31. Ending HIV Organ Donation Ban Could Eliminate Transplant Waiting List for People 
with HIV, AIDSMEDS (Mar. 30, 2011), http://www.aidsmeds.com/articles/hiv_transp
lant_organ_1667_20165.shtml [hereinafter Ending HIV Organ Donation Ban]. 
 32. Id.  A 1998 study revealed that the vast majority of surveyed clinics “would not 
transplant a kidney from a cadaveric (88%) or a living donor (91%) into an 
asymptomatic HIV-infected patient who is otherwise a good candidate for 
transplantation.”  Roland, supra note 14. 
 33. Although different types of antibody tests may be used for HIV screening, “[a]ll HIV 
tests used in the U.S. detect HIV-1,” the most common form of HIV in the United 
States, and “some tests have been developed that can also detect HIV-2.  Am. Ass’n. 
for Clinical Chemistry, HIV Antibody, LAB TESTS ONLINE, http://labtestsonline.org/un
derstanding/analytes/hiv-antibody/tab/test/ (last modified Feb. 24, 2015).  These 
“[c]ombination tests . . . detect the HIV antibody and the HIV antigen called the p24 
antigen,” which is typically high in the beginning stages of the infection.  Id.  There 
are several different methods of testing, including a blood or oral sample obtained by 
one’s doctor, or an at-home collection kit.  Id.  
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below should be excluded from donation of organs or tissues unless 
the risk to the recipient of not performing the transplant is deemed to 
be greater than the risk of HIV transmission and disease . . . .”34  
Behaviors included “[m]en who have had sex with another man in the 
preceding 5 years.”35  In 1996, the CDC became a little more liberal 
with its restrictions, stating “transplant teams are encouraged to 
accept and transplant organs from medically appropriate donors who 
test HIV-antibody negative but have behavioral risk criteria for HIV 
infection after the transplant teams have discussed the risks and 
benefits with potential recipients and/or their families.”36  
However, as scientific developments in HIV treatment grew, so too 
did the clamoring to reverse the longtime ban on HIV-infected organ 
donation.  With the success of active antiretroviral therapy,37 fewer 
people are dying of AIDS-related complications today.38  Instead, 
more individuals are now dying of disease processes, including end-
stage liver and renal diseases.39  This recent trend led to a 2011 study 
conducted by Johns Hopkins University School of Medicine, 
published in the American Journal of Transplantation.40  The study 
sought to address the dilemma of having needy HIV-positive 
recipients who could not receive transplants from willing HIV-
positive potential donors.41  Pulling data from the Nationwide 
 
 34. Doe v. Univ. of Chi. Med. Ctr., 20 N.E.3d 1, 3 (Ill. App. Ct. 2014) (emphasis added) 
(quoting Martha F. Rogers et al., Ctrs. for Disease Control & Prevention, Guidelines 
for Preventing Transmission of Human Immunodeficiency Virus Through 
Transplantation of Human Tissue and Organs, 43 MORBIDITY & MORTALITY WKLY. 
REP., May 20, 1994, at 12, http://stacks.cdc.gov/view/cdc/13462 [hereinafter CDC 
Guidelines]).  
 35. Id. (alteration in original) (quoting CDC Guidelines, supra note 34). 
 36. Id. (quoting Clarification of Human Immunodeficiency Virus Screening Practices for 
Organ Donors, 61 Fed. Reg. 56,548, 56,549 (Nov. 1, 1996)). 
 37. “Antiretroviral therapy (ART) is the combination of antiretroviral medicines used to 
slow the rate at which HIV [multiplies] in the body.”  ART aims to reduce the amount 
of virus in an individual’s body.  HIV: Antiretroviral Therapy (ART) - Topic 
Overview, WEBMD.COM, http://www.webmd.com/hiv-aids/tc/hiv-highly-active-
antiretroviral-therapy-haart-topic-overview (last visited Nov. 13, 2015) [hereinafter 
ART - Topic Overview]. 
 38. See UNAIDS, AIDS by the Numbers, at 4, U.N. Doc. JC2571/1/E (2013),  
http://www.unaids.org/sites/default/files/media_asset/JC2571_AIDS_by_the_numbers
_en_1.pdf; see also Roland, supra note 14; ART - Topic Overview, supra note 37. 
 39. Roland, supra note 14. 
 40. See B. J. Boyarsky et al., Estimating the Potential Pool of HIV-Infected Deceased 
Organ Donors in the United States, 11 AM. J. TRANSPLANTATION 1209, 1209–10 
(2011), http://onlinelibrary.wiley.com/doi/10.1111/j.1600-6143.2011.03506.x/epdf; 
see also Ending HIV Organ Donation Ban, supra note 31. 
 41. See Boyarsky et al., supra note 40; Ending HIV Organ Donation Ban, supra note 31. 
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Inpatient Study and the HIV Research Network, the Johns Hopkins 
team estimated the number of deaths by HIV-positive people “where 
viable organs might have been available for transplantation.”42  The 
number of deaths in this category totaled “534 each year between 
2005 and 2008 in the Nationwide Inpatient Study and . . . 494 each 
year between 2000 and 2008 in the HIV Research Network.”43  
Translated, this information means that “500 HIV-infected patients 
would be eligible for life-saving transplants each year if the ban was 
overturned, and allowing those transplants would shorten wait times 
for non-HIV infected patients.”44  Based upon this study, the 
American Society of Transplant Surgeons, American Society of 
Transplantation, Association of Organ Procurement Organizations, 
and the United Network for Organ Sharing started to urge lawmakers 
to overturn the ban, releasing a joint statement on the issue in 2011.45  
It was this background that eventually led lawmakers to enact the 
HOPE Act.  
While the thought of transplanting HIV-infected organs is 
revolutionary for the United States, other countries have already 
pioneered HIV-positive-to-HIV-positive kidney transplants.46  Since 
2008, Dr. Elmi Muller, a transplant surgeon in Cape Town, South 
Africa, has conducted at least 26 such transplants.47  Of these 
transplants, only two have failed as of November 2013.48  While most 
donations have been from cadavers, the first transplant between a 
living HIV-positive donor and recipient recently occurred in Tel Aviv 
with great success.49  The doctors in Israel stated that “due to much 
experience in South Africa with kidney and even liver donations from 
 
 42. Ending HIV Donation Ban, supra note 31. 
 43. Id. 
 44. Nicole Jones, Hopkins Researchers Help Overturn Government Ban, WMAR BALT. 
(Nov. 21, 2013, 11:16 PM), http://www.abc2news.com/news/health/johns-hopkins-
researchers-help-overturn-government-ban. 
 45. Angela Townsend, Should the Ban on HIV-Positive Organ Transplants Be Lifted? 
CLEVELAND.COM (Sept. 12, 2011, 6:00 PM), http://www.cleveland.com/healthfit/inde
x.ssf/2011/09/should_the_ban_on_hiv-positive.html. 
 46. See Sara Reardon, United States to Allow Transplants of HIV-Infected Organs, 
NATURE.COM (Nov. 13, 2013), http://www.nature.com/news/united-states-to-allow-
transplants-of-hiv-infected-organs-1.14170. 
 47. Id. 
 48. Id. 
 49. Judy Siegel-Itzkovich, Sourasky Announces World’s First Kidney Donation, 
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brain-dead patients to HIV patients, the success rate of transplants 
has risen to be almost equal to those of non-carriers.”50 
So why would countries such as South Africa or Israel trump the 
United States in terms of its progressive view on HIV-positive-to-
HIV-positive transplants?  The most obvious answer is the countries’ 
greater needs for transplants for HIV-positive individuals given large 
populations of HIV-infected citizens.  But this answer does not seem 
correct.  Approximately twenty percent of South Africa’s population 
is infected with HIV.51  While one may think the incidence of HIV is 
much less in the United States, as previously noted, the CDC 
estimates that 1.2 million people aged thirteen years and older are 
living with HIV, including over 156,300 who are unaware they are 
affected.52   
A more appropriate reason for the United States’ slow response to 
HIV-positive transplants may lie in the unknown risks of such 
transplants.  Of particular concern is “‘superinfecting’ a HIV-positive 
patient with a . . . strain of the virus” from the donated organ.53  Also, 
it remains unclear as to how antiretroviral drugs will interact with 
anti-rejection drugs taken by transplant patients.54  There are concerns 
that immunosuppressive drugs55 that prevent organ rejection would 
worsen HIV progression, for such drugs weaken one’s immune 
system, which is already compromised in an HIV-patient.56  There is 
also a fear of mislabeling an HIV-infected organ, which might result 
in transplantation into an HIV-negative patient.57  Even Dr. Muller 
highlights a continued need for research to perfect the safety of 
positive-to-positive transplants.58  It is for these reasons that the new 
law has ongoing research and review standards.59  But, “[r]ecent 
studies have shown that transplant outcomes in selected HIV-positive 
 
 50. Id. 
 51. Reardon, supra note 46. 
 52. HIV in the United States, supra note 18. 
 53. Reardon, supra note 46. 
 54. Id. 
 55. Immunosuppressant drugs suppress the body’s immune system to lower the body’s 
ability to reject a transplanted organ by decreasing the body’s reaction to the foreign 
organ.  Anna Giorgi, Immunosuppressant Drugs, HEALTHLINE (June 20, 2013), 
http://www.healthline.com/health/immunosuppressant-drugs#Overview1. 
 56. Liver Transplant, NAM AIDSMAP, http://mobile.aidsmap.com/Liver-
transplant/page/1731924 (last visited Nov. 13, 2015).  
 57. Ending HIV Organ Donation Ban, supra note 31.  
 58. Reardon, supra note 46. 
 59. 42 U.S.C. § 274f-5 (Supp. I 2013). 
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people can be nearly as good as those seen in people without HIV.”60  
Transplants seem most successful in patients with well-controlled 
HIV, and some patients are able to tolerate antiretroviral drugs after 
receiving a liver transplant.61   
C. Current Legislation’s Likely Consequences 
The current legislation dealing with the new transplant policy in the 
United States is not very extensive.  It reads as follows: 
(a) In general:  
Not later than 2 years after November 21, 2013, the 
Secretary shall develop and publish criteria for the 
conduct of research relating to transplantation of organs 
from donors infected with human immunodeficiency 
virus (in this section referred to as “HIV”) into 
individuals who are infected with HIV before receiving 
such organ. 
(b) Corresponding changes to standards and regulations 
applicable to research:  
Not later than 2 years after November 21, 2013, to the 
extent determined by the Secretary to be necessary to 
allow the conduct of research in accordance with the 
criteria developed under subsection (a)— 
(1) the Organ Procurement and Transplantation 
Network shall revise the standards of quality 
adopted under section 274(b)(2)(E) of this title; 
and 
(2) the Secretary shall revise section 121.6 of title 
42, Code of Federal Regulations (or any successor 
regulations). 
(c) Revision of standards and regulations generally:  
Not later than 4 years after November 21, 2013, and 
annually thereafter, the Secretary, shall— 
(1) review the results of scientific research in 
conjunction with the Organ Procurement and 
 
 60.  Liver Transplant, supra note 56. 
 61.  Id. 
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Transplantation Network to determine whether the 
results warrant revision of the standards of quality 
adopted under section 274(b)(2)(E) of this title 
with respect to donated organs infected with HIV 
and with respect to the safety of transplanting an 
organ with a particular strain of HIV into a 
recipient with a different strain of HIV; 
(2) if the Secretary determines under paragraph (1) 
that such results warrant revision of the standards 
of quality adopted under section 274(b)(2)(E) of 
this title with respect to donated organs infected 
with HIV and with respect to transplanting an 
organ with a particular strain of HIV into a 
recipient with a different strain of HIV, direct the 
Organ Procurement and Transplantation Network 
to revise such standards, consistent with section 
274 of this title and in a way that ensures the 
changes will not reduce the safety of organ 
transplantation . . . .62 
While this legislation has been enacted into law, it will most likely 
be at least several months before the United States hears of the first 
HIV-positive-to-HIV-positive transplant.  The current legislation 
“directs the Department of Health and Human Services . . . and the 
Organ Procurement and Transplant Network . . . to develop standards 
[that will] make these transplants possible” by 2015.63  In particular, 
by November 2015, the Secretary “shall develop and publish criteria 
for the conduct of research relating to transplantation of organs from 
donors infected with [HIV] into individuals who are infected with 
HIV before receiving such organ.”64  These standards are to be 
updated and reviewed no later than four years after November 21, 
2013, and annually thereafter in order to accommodate current 
scientific research.65     
The result of the HOPE Act may be more transplants for HIV-
positive individuals and thus more lives saved.  In a recent case 
alleging negligence in an HIV-infected organ transplant, a doctor 
noted that “a patient who received a kidney from an infected donor 
would most likely be infected with HIV” and further noted that “a 
 
 62. 42 U.S.C. § 274f-5 (footnote omitted). 
 63. Krans, supra note 29.   
 64. 42 U.S.C. § 274f-5. 
 65. Id. 
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patient who is at the top of the transplant list and likely to receive a 
noninfected organ very soon was better off refusing the infected or 
possibly infected [organ].”66  Thus, while an HIV-negative recipient 
awaits a non-infected organ, the infected organ could be placed in an 
HIV-positive individual with no harm resulting to the unaffected 
recipient.67  Essentially, individuals partaking in high-risk behaviors 
or who are diagnosed as having HIV can still serve a donative 
purpose without risking infection to an HIV-negative recipient, and 
an uninfected recipient may be more willing to wait for an uninfected 
organ knowing that more donations equals less time on the transplant 
waiting list.  It is too soon to back up this idealistic outcome with 
empirical evidence, but perhaps this could be one good consequence 
that results from the new HOPE Act. 
II. CHANGING THE STANDARD TO ALLOW FOR 
TRANSPLANTS AFTER CARDIAC DEATH 
Once an individual is declared brain dead, organ donation may 
occur;68 however, changing this standard to allow for organ donation 
when cardiac death is irreversible may, in fact, increase the amount 
of available organs to be donated. 
 A.The Current Transplant Standard: Brain-Death 
It is universally accepted that an individual is deceased when his or 
her brain no longer has activity.69  Nevertheless, mechanical 
ventilators and other medical techniques can continue to allow the 
heart to beat and the blood to circulate for a prolonged period of 
time.70  The current standard at which time a doctor may consider an 
individual for organ donation is at the point of brain death.71  When a 
patient is no longer responsive, a physician, usually a neurosurgeon 
or neurologist, performs a series of tests to determine if brain death 
has occurred.72  Patients are declared brain dead when there is no 
brain activity and when the patient cannot breathe on his own, for 
 
 66. Doe v. Univ. of Chi. Med. Ctr., 20 N.E.3d 1, 10 (Ill. App. Ct. 2014). 
 67. Id.  
 68. Ajay Kumar Goila & Mridula Pawar, The Diagnosis of Brain Death, 13 INDIAN J. 
CRITICAL CARE MED. 7, 7 (2009), http://www.ijccm.org/temp/IJCCM1317-
3497178_094251.pdf. 
 69. Id.  
 70. Id. at 7–8. 
 71. Id. at 7.  
 72. U.S. Dep’t of Health and Human Servs., Organ Donation: The Process, 
ORGANDONOR.GOV, http://www.organdonor.gov/about/organdonationprocess.html#pro
cess3 (last visited Nov. 13, 2015). 
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these symptoms are irreversible.73  Brain death occurs in less than one 
percent of all deaths in the United States.74  Such patients usually 
“suffer an injury to the brain resulting from a trauma, stroke or lack 
of oxygen.”75 
After an individual is declared brain dead, the hospital notifies its 
local organ procurement organization and gives the organization 
information about the patient to confirm whether he is a candidate for 
donation.76  If the deceased has enrolled as a donor, then this 
enrollment serves as consent, but if not, consent must be received 
from the next of kin.77  But what if the declaration of death relied on a 
different standard, one that could possibly start the transplant process 
well before brain death occurs?  Enter the consideration of donation 
after cardiac death.     
 B. A Proposed New Standard of Donation After Cardiac-Death 
and Its Implications 
Cardiac death is different than brain death.  Sudden cardiac death is 
an unexpected death caused by loss of heart function.78  “It is 
triggered by an electrical malfunction in the heart that causes an 
irregular heartbeat[,]” and patients must receive treatment within 
minutes or they will die.79  While sudden cardiac death is reversible 
in most victims if treated immediately,80 it is “the largest cause of 
natural death in the United States, causing about 325,000 adult deaths 
. . . each year.”81  This condition is different than a heart attack.  “A 
heart attack occurs when a blocked artery prevents oxygen-rich blood 
from reaching a section of the heart.”82  If the artery is not opened, 
 
 73. Id. 
 74. Understanding Death Before Donation, GIFT OF A LIFETIME, 
http://www.organtransplants.org/understanding/death/ (last visited Nov. 13, 2015). 
 75. Id. 
 76. Organ Donation: The Process, supra note 72. 
 77. Id. 
 78. Sudden Cardiac Death, CLEV. CLINIC, 
http://my.clevelandclinic.org/services/heart/disorders/arrhythmia/scd (last visited Nov. 
13, 2015) [hereinafter CLEV. CLINIC]. 
 79. Heart Attack or Sudden Cardiac Arrest, AM. HEART ASS’N, 
http://www.heart.org/HEARTORG/Conditions/More/MyHeartandStrokeNews/Heart-
Attack-or-Sudden-Cardiac-Arrest-How-Are-They-
Different_UCM_440804_Article.jsp (last updated Aug. 19, 2015). 
 80. Id. 
 81. CLEV. CLINIC, supra note 78; Heart Attack or Sudden Cardiac Arrest, supra note 79. 
 82. Heart Attack or Sudden Cardiac Arrest, supra note 79. 
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the part of the heart fed by that artery begins to die; thus, the longer a 
patient is without treatment, the more damage is done to the heart.83 
“Donor after cardiac death (DCD) means an individual who 
donates after his or her heart has irreversibly stopped beating.  A 
donor after cardiac death may be termed a non-heartbeating or 
asystolic donor.”84  No specific statutory authorization of DCD exists 
in federal law; instead, DCD relies on “existing statutory framework 
governing the planned withdrawal of life supportive measures in 
terminally ill patients, the ability of those patients or their families to 
make an anatomical gift, and the pronouncement of death in those 
patients by cardiopulmonary criteria.”85  Thus, the process for DCD 
starts when life-supportive measures are withdrawn from a terminally 
ill patient either by consent of the family or an advanced directive of 
the patient.86 
The use of DCD organs is fairly routine in many European 
countries as well as South America, Australia, and Japan.87  
Specifically, there are five categories of DCD donors: two categories 
for donors who die unexpectedly and three categories for donors 
whose death is anticipated.88  However, different legislations 
regarding consent for organ donation and different attitudes 
concerning the withdrawal of futile life-sustaining treatments make 
DCD a controversial topic.89  Of course, the existence of consent, 
either by the donor or by a family representative, is mandatory and 
can have ethical and legal implications of its own.  Grieving family 
members may argue that a donor’s consent for organ donation meant 
consent to donation after brain death, not cardiac death.90  
Furthermore, finding a family member authorized to make end-of-life 
decisions in the absence of a patient directive is legally required and 
 
 83. Id. 
 84. 42 C.F.R. § 486.302 (2014). 
 85. Frederick J. White III & J. Kelly Elrod, Institutional Ethics & Comm. of the Willis-
Knighton Health Sys., Organ Donation After Cardiac Death: A Louisiana Hospital 
Ethics Committee Perspective, 39 S.U. L. REV. 71, 85 (2011). 
 86. Id. at 86 & n.58. 
 87. Umberto Maggiore et al., Strategies to Increase the Donor Pool and Access to Kidney 
Transplantation: An International Perspective, 30 NEPHROLOGY DIALYSIS 
TRANSPLANTATION 217, 221 (2015), http://ndt.oxfordjournals.org/content/30/2/217.ful
l.pdf+html?sid=3ce37119-b5e8-40b5-b9ff-e31baa83cd1e. 
 88. Id. 
 89. Id. 
 90. Bernadette Richards & Wendy A. Rogers, Organ Donation After Cardiac Death: 
Legal and Ethical Justifications for Antemortem Interventions, 187 MED. J. AUSTL. 
168, 168 (2007), https://www.mja.com.au/system/files/issues/187_03_060807/ric1016
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thus may prove difficult for individuals without immediate family 
present.91  Of particular concern to doctors is the ethical conflict 
between DCD donations, when an individual is not considered brain 
dead, and the Hippocratic Oath of “do no harm.”92  Does the invasive 
removal of organs from a patient who is not declared brain dead harm 
the patient and thus conflict with a doctor’s ethical oath? 
Several concerns surround a doctor’s implementation of DCD, 
especially in controlled DCD patients.93  First, interventions 
administered ante-mortem to preserve the organs of a potential donor 
can cause harm and thus infringes on a doctor’s ethical oath to do no 
harm and to act only in the interest of the patient.94  DCD supporters 
respond by stating that ante-mortem intervention is not proven to 
cause harm to the patient.95  Others cite the doctrine of double effect 
from medical ethics.  According to this doctrine,  
[A]n action that has both good and bad effects, such as 
administering morphine to a terminally ill patient, which can 
both relieve pain and hasten death, may be permissible if 
four conditions are met: 1) the act is not itself immoral—it 
may be good, but is at least indifferent; 2) the intent in 
performing the act is only the good effect, although the bad 
effect may be foreseen; 3) the bad effect must not be a 
means to the good effect; and 4) the act is performed for an 
adequately serious reason.96 
Thus, ante-mortem interventions would seem to meet these 
conditions and be ethically permissible.97   
In uncontrolled DCD patients, those who have already suffered 
cardiac arrest and failed resuscitative measures, this ethical 
conundrum is less concerning.98  However, other concerns emerge in 
these instances.  Since other, more aggressive techniques can be used 
to resuscitate an individual, labeling an uncontrolled DCD patient’s 
 
 91. Id. at 169. 
 92. Id. at 168. 
 93. Controlled DCD occurs in those patients whose heart has not necessarily suffered 
cardiac arrest or sustained failed resuscitative measures.  Jeremy R. Simon et. al., 
Donation After Cardiac Death and the Emergency Department: Ethical Issues, 21 
ACAD. EMERGENCY MED. 79, 80–81 (2014). 
 94. Id. 
 95. Id. at 81.  
 96. Id. 
 97. Id. 
 98. Id. at 82. 
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heart as irreversibly dead can be tricky.99  Technological advances, 
such as extracorporeal membrane oxygenation (ECMO)100 make the 
phrase “irreversible cessation of circulatory and respiratory 
function[s]” difficult to understand.101  Applying a strict interpretation 
to this phrase, ECMO patients would technically not be seen as dead 
since they would have circulation of oxygenated blood.102  Thus, 
removing an ECMO patient from this device for purposes of organ 
harvesting could open doctors up to criminal liability since the patient 
would technically not be seen as dead.103  Furthermore, there may be 
a concern that doctors will not try as hard to resuscitate uncontrolled 
DCD patients, hoping their organs will be of value to eager 
recipients.104  These ethical considerations make the concept of DCD, 
both controlled and uncontrolled, controversial in the medical world. 
Even more disconcerting for both medical ethicists and the legal 
community is the term “irreversible death” utilized for purposes of 
DCD.  Legally, the concept of uncontrolled versus controlled DCD 
poses problems.  In particular, “nearly every state . . . has adopted” a 
form of the Uniform Determination of Death Act (UDDA), which 
“outlines the two means by which death can be determined for organ 
transplantation.”105  However, the UDDA does not address “how long 
cardiac and respiratory functions must have ceased before they can be 
considered irreversible,” and thus variations in determinations of 
death occur.106  This conundrum leaves the doctor in a precarious 
position between waiting long enough to declare cardiac death 
irreversible and not waiting too long to render organs unviable.107  
 
 99. Id. 
 100. “Extracorporeal membrane oxygenation (ECMO) is a treatment that uses a pump to 
circulate blood through an artificial lung back into the bloodstream . . . .”  U.S. Nat’l 
Library of Med., U.S. Dep’t of Health and Human Servs., Extracorporeal Membrane 
Oxygenation, MEDLINEPLUS, http://www.nlm.nih.gov/medlineplus/ency/article/00723
4.htm (last updated Nov. 2, 2015). 
 101. Abel, supra note 4, at 600 (quoting Robert M. Veatch, Donating Hearts After Cardiac 
Death—Reversing the Irreversible, 359 NEW ENG. J. MED. 672, 672 (2008)); accord 
UNIF. DETERMINATION OF DEATH ACT § 1 (NAT’L CONFERENCE OF COMM’R ON UNIF. 
STATE LAWS 1980). 
 102. Abel, supra note 4, at 603. 
 103. Id. 
 104. Simon et al., supra note 93, at 82. 
 105. Abel, supra note 4, at 600. 
 106. Id. 
 107. Id. at 600–01. 
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C.  How Changing the Standard May Increase Available Organs 
In the United States, DCD donors consist of only about ten percent 
of organ donations.108  Considering the greater number of cardiac 
deaths than brain deaths that occur each year, perhaps making cardiac 
death versus brain death the standard to start the organ donation 
process would result in more organs to donate.  A consultant for The 
New England Journal of Medicine made this startling claim in 2007, 
stating this theory “has been demonstrated at organ banks in 
Wisconsin, the Boston metropolitan region and the Finger Lakes 
region of New York . . . where cardiac death donors account for more 
than 20 percent of all deceased donors.”109  Such donors included 
“patients on ventilators after devastating and irreversible brain 
injuries, as might follow a hemorrhagic stroke, as well as patients 
with high spinal cord injuries and terminal musculoskeletal diseases 
like ALS, for whom further medical treatment is deemed futile.”110  
Under the brain-death standard for organ donation, these patients are 
technically not dead for the purpose of organ harvesting.111  However, 
if these patients were considered suitable donors under a DCD organ 
donation standard, life-support measures could be ended and their 
organs successfully harvested.112   
Currently, DCD only becomes a viable alternative for those who 
have previously consented to the removal of life support or whose 
family has done so.113  Ultimately, the harvesting of organs from 
cardiac death patients should not be looked at as a way to sidestep the 
criteria for brain death but as a way to afford donors or their families 
“donation that complies with patient or authorized family 
directives.”114   
 
 108. Maggiore et al., supra note 87. 
 109. See Jane Brody, The Solvable Problem of Organ Shortages, N.Y. TIMES (Aug. 28, 
2007), http://www.nytimes.com/2007/08/28/health/28brod.html?_r=1&. 
 110. Id. 
 111. Id. 
 112. Id.  “DCD has evolved into  routine clinical practice that currently supplies >10% of 
all deceased-donor kidneys in the United States . . . .”  Maarten G. Snoeijs et al., 
Kidneys from Donors After Cardiac Death Provide Survival Benefit, 21 J. AM. SOC’Y 
NEPHROLOGY 1015, 1016 (2010), http://jasn.asnjournals.org/content/21/6/1015.full.pd
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 113. Donation After Cardiac Death (DCD), LIFEPOINT, INC., http://www.lifepoint-
sc.org/facts_cardiac.htm (last visited Nov. 13, 2015).  
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III. EDUCATING INDIVIDUALS, ESPECIALLY MINORITIES, 
ABOUT DONATION 
It is alleged that “the organ transplant system operates with a built-
in bias against the poor,” making minorities “nearly half as likely to 
receive organs,” despite their greater demand.115  This disparity may 
be linked to disparate education about organ donation.  There have 
been many studies indicating that, for both minority and majority 
groups, education leads to a greater possibility of organ donation.116    
A. A Greater Minority Need for Transplants 
The need for transplants in some minority groups is 
disproportionately high as a result of a higher incidence of medical 
conditions for particular minorities.117  The U.S. Department of 
Health and Human Services explains that “African Americans, 
Asians and Pacific Islanders, and Hispanics/Latinos are three times 
more likely than Caucasians to suffer from end-stage renal (kidney) 
disease, . . . .  [and] [a]lmost 34 percent of the more than 101,000 
people on the national waiting list for a kidney transplant are African 
American.”118  Further, “African Americans make up 12% of the 
region’s overall population, but represent 43% percent of patients on 
the kidney transplant waiting list.”119  Similarly, Hispanics are in the 
same position, being three times more likely than Caucasians to 
suffer from a disease requiring a kidney transplant.120 
While “organs are not matched according to [one’s] race[,] . . . all 
individuals waiting for an organ transplant will have a better chance 
of receiving one if there are large numbers of donors from their 
racial/ethnic background.”121  This is due to the fact that individuals 
of similar ethnicity are more likely to be of compatible blood types 
 
 115. Kristen Gwynne, How the Organ Transplant System Is Stacked Against the Most 
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and tissue markers.122  For example, “the African-American 
population has a high prevalence of type B blood, which is more rare 
in the general population.”123  The lack of compatible donors may 
explain why it generally takes longer for an African American to 
obtain a lifesaving organ.124 
B. Education May Encourage Donation and May Get Recipients on 
More Transplant Lists 
While African Americans constitute about 13% of organ donors in 
total,125 thirty percent of individuals currently waiting for an organ 
donation are African American.126  If more minorities, particularly 
African Americans, were educated about donations and encouraged 
to donate, perhaps the greater likelihood of organ matches would 
equal more successful transplants and thus fewer individuals on the 
transplant list.  Education can begin by making the steps for signing 
up as a donor more apparent.  Different states have different 
processes for enrollment, with some allowing enrollment through the 
DMV while others require online enrollment.127  While this may not 
seem confusing for some, educating individuals, specifically those 
without access to quality health care, as to how to donate and about 
the importance of donation, may increase their likelihood of 
donation.  Furthermore, expending resources to educate living donors 
about the greater need for organs may increase donation and result in 
large savings in healthcare expenditures.128 
In addition, education about the regional based system may 
encourage more possible recipients to place their names on multiple 
regional lists, resulting in a greater chance of receiving an organ.  
Currently, the country is divided into eleven allocation regions, with 
each region having its own organ procurement organization to 
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 123. See Gwynne, supra note 115. 
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“oversee[] the selection of organ transplant patients.”129  Because of 
the disparate populations of the regions, “[s]ome regions have more 
donors or transplant centers than others, making the regional list 
lengths unequal.”130  Organs are allocated regionally to the sickest, 
best-matched patients; however, if a region has no viable matches, 
the organ moves to a nearby location, applying the same matching 
criteria.131  Individual recipients may put their name on multiple 
waiting lists, especially on regional lists of neighboring states, to 
have a better chance of finding a donor match.132  Karen Cummings, a 
specialist at the New York Organ Donation Network, states that the 
issue for many individuals, especially minorities, “is making sure 
they know that, for example, Pennsylvania, Connecticut, those are 
areas in your region.”133  Similarly, leading experts in the field agree 
that “community empowerment, education and encouraging 
communities to discuss wishes upon death are key to increasing 
organ transplantation in any community.”134 
But education does not just promote organ donations for donors; 
educating doctors also encourages organ donations in general.  
Education for doctors includes programs that teach care-givers how 
to broach the topic with a more sensitive approach and working in a 
team to lend support to the family faced with the decision.135  Most 
recently, “[t]hrough partnerships with local organ procurement 
organizations, medical schools and teaching hospitals are educating 
residents, fellows, and other members of their medical staffs not only 
in better communication with families during difficult times but also 
in ways to introduce families to organ procurement 
representatives.”136  While success of education programs may be 
hard to quantify, the Association of Organ Procurement Organization 
has noted that “a determined focus on opportunities for organ 
donation has worked in the past to improve education and 
understanding.”137  For example, in 2003, the U.S. Department of 
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Health and Human Services, through its national Donation and 
Transplantation Collaborative, worked to educate families and care 
providers and, as a result, donation rates increased from 50% to 
75%.138  While donation rates have plateaued since this initiative,139 
other regions have proven that education is still a means by which to 
increase organ donation.  At Johns Hopkins Hospital, end-of-life 
education increased donations from 44% in 2002 to 80% in 2014.140 
IV. OTHER POSSIBLE SOLUTIONS: PAYMENTS, 
ADVERTISING, PRIORITY LISTS, AND CHANGING AGE 
REQUIREMENTS 
While the HOPE Act, education programs for both donors and 
recipients, and a change in donation standards are the most widely 
discussed ways in which the number of available organs can be 
increased, there are other, less talked about, means by which the 
supply of organs can be increased.  Setting aside ethical 
considerations, individuals have proposed paying and advertising for 
organ donations, as well as giving priority on transplant lists to those 
patients who are organ donors.141  In addition, there is a disparity 
between the number of elderly donors and the rate at which these 
harvested organ are transplanted.142  Perhaps with the implementation 
of new requirements in 2014, this disparity will be lessened, resulting 
in a larger number of transplantable organs. 
A. Payments, Solicitations, and Priority Status  
In a 2011 research study conducted by the University of 
Pennsylvania, professors tested whether organ donation would 
increase if transplant waiting list priority was given to registered 
organ donors.143  “The underlying economic rationale . . . is that by 
providing priority on the waiting list, you are giving an incentive to 
register as a donor.”144  In order to test their theory, the professors set 
up a gaming system to judge whether priority registration would lead 
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to a greater willingness to donate.145  The results overwhelmingly 
indicated that individuals were willing to register in order to receive 
priority transplants.146  A variation of this incentive program may be 
to require individuals who receive an organ to then either give an 
organ in return or to register as an organ donor.147  Likewise, some 
believe an “opt-out” provision, one in which individuals are 
automatically registered as donors and must actively opt out of this 
choice, may increase organ donation.148   
The University of Pennsylvania researchers also broached another 
controversial means by which organ donations may increase.  They 
gave either a discount or a rebate for agreeing to donate, providing a 
monetary incentive to register as a donor.149  “[T]hese monetary 
incentives worked just as well as giving [waiting-list] priority to 
donors,”150 and thus providing financial incentive could increase the 
availability of transplantable organs.151  The receipt of a benefit for a 
donation, especially for living donors, makes sense.  Living donor 
donations are rare because, unlike a deceased donor, a living donor 
must make a personal sacrifice, bearing any health risks associated 
with the donation.152  Thus, by requiring an incentive such as priority 
receipt of an organ or monetary compensation,153 more living donors 
may be willing to donate.   
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The concept of payment for or solicitations of donations is ethically 
controversial.154  Currently, there is a federal prohibition on the sale 
of human organs for transplantation by the National Organ 
Transplant Act (NOTA).155  However, arguments in favor of financial 
incentives state that such a system “would increase the supply of 
organs and thereby secure the basic ethical concern of saving lives 
that may otherwise be lost due to the lack of this resource.”156  
Furthermore, the medical care system could benefit: assuming 500 
additional live donors opted to donate organs for money, a $30 
million savings could result, allowing for other transplant-related 
programs.157  On the other hand, there are compelling arguments 
against financial incentives.  Opponents of such financial incentives 
“point out that there would be potentially decreased emotional gain 
for the donor family, decreased respect for life and the sanctity of the 
human body, and a loss of the personal link that currently exists in 
the donation process.”158  There are also concerns about the impact 
such compensation may have on the economically disadvantaged 
population willing to sell their kidneys for cash.159  Thus, methods by 
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 159. A further concern regarding the underprivileged who receive transplants is the 
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Congress’ extension of Medicare coverage for antirejection drugs may increase the 
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which such concerns could be ameliorated have been proposed, 
including “limiting payments to sales of cadaver organs, limiting the 
compensation that may be paid for each organ, regulating the 
exchange such that compensation is paid by a third party government 
agency and not directly from recipient to donor, and setting donor 
health standards.”160   
There are also differing views as to how the sale of organs is 
connected or related to property rights.161  “One view is that the sale 
of organs is impossible because the body is not property in a 
commercial sense.”162  A second view does not object to the sale of 
organs but objects to the commodification of the body.163  A final 
view recognizes that commercial activity occurs with the “trading” of 
body parts and instead questions whether compensation for donated 
organs should be paid to the donor or donor’s estate.164  These various 
views concerning organs as property further complicate the already 
controversial ethical debate surrounding the sale of organs.  
A similar ethical debate also surrounds the solicitation of organs.  
A growing number of individuals, labeled “transplant tourists,” have 
begun to travel in order to find a transplantable organ in a donor 
country.165  Similarly, others have begun to travel the web to find a 
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While this remains a concern for some, others have contemplated safeguards that 
would guard against this, such as regulating an upper limit on the amount of 
compensation that can be given for a donation, limiting the market to cadaver organs 
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transplant, using websites such as MatchingDonors.com.166  The 
process at matching donor websites is described as follows: 
[P]otential recipients pay a membership fee to post their photos and 
personal stories describing their transplant organ needs.  Potential 
donors pay no fee and are able to browse the profiles of over 4,000 
potential recipients.  If a potential donor is interested in a potential 
recipient, the potential donor can contact the potential recipient to 
begin a dialogue and, if both agree, to proceed with the organ 
donation process.167  
Proponents for internet solicitation claim that a valuable service 
allows altruistic potential donors to find needy patients in a safe 
manner.168  Furthermore, other safeguards prevent coercion, such as 
the psychological screening procedures for live donors implemented 
at many hospitals.169  Other medical facilities may refuse to perform 
transplants on individuals who met through an internet site.170  
Legally, internet solicitation is allowed under § 6(A)(3) of the 1987 
version of the Uniform Anatomical Gift Act, which “permits directed 
organ donation for transplantation purposes” without regard to how 
the recipient or donor met.171  
Opponents of internet solicitation claim that such sites help 
circumvent the law as willing donors are paid under the table for 
organs by recipients.172  Furthermore, critics claim that, by bypassing 
transplant wait lists, soliciting recipients weaken the formal 
transplant wait list structure and allow for a disorganized allocation 
of organs.173  Critics also cite the superficiality of internet solicitation, 
claiming individuals may select recipients on criteria such as beauty 
or race.174  Finally, there is concern about the veracity of potential 
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recipients’ profiles due to the lack of legal safeguards regulating such 
websites.175 
B. Ending Age-Restrictions on Donations and Receipt 
Up until the 1990s, donor organs from individuals over fifty-five 
were rarely used since organs donated from older individuals resulted 
in reduced graft function and reduced recipient and graft survival.176  
However, age matching between donor and recipient has been 
adopted by most European countries,177 and the United States is now 
catching on to the trend.  In the United States, despite the use of 
kidneys from donors older than sixty, the percentage of organs that 
are harvested from this population yet not transplanted is 40%.178  
The major reasons that these organs are discarded are unfavorable 
biopsy findings.179  However, a new change may mean greater use for 
these once discarded organs.  The United Network of Organ Sharing 
Kidney Transplantation Committee approved and implemented a 
policy in 2014 that may result in fewer discarded organs.180  The new 
policy is based on the Kidney Donor Profile Index (KDPI), a measure 
of donor quality, that is an improvement of the older standards.181  
“KDPI is a percentile rank, based on a number of donor risk 
indicators (KDPI = 85 means that 85% of donors are of better 
quality).”182  Transplant programs can accept different quality 
kidneys and match kidneys according to the recipient’s age and 
medical circumstances “by establishing candidate-specific KDPI 
acceptability thresholds.”183   
A program such as this has already experienced success in 
European countries.  In 1999, the Eurotransplant foundation initiated 
the Eurotransplant Senior Programme (ESP).184  Under the program, 
donor kidneys that are older than sixty-five are matched to recipients 
older than sixty-five to allow the most use of such marginal organs 
and to reduce wait times for elderly individuals.185  Survival rates of 
ESP program participants have proven similar to those of elderly 
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recipients receiving a younger graft.186  Other European countries are 
even more adventurous.  In Italy, for example, donor kidneys that are 
older than sixty-five can be given to younger recipients.187   
In the United States, the problem of discarded organs may not only 
be attributable to the age of a person but also to the age of an organ.  
Many organs taken from deceased donors are discarded every year 
since transplantation does not occur within the twenty-four to thirty-
six hour window from recovery to evaluation to transplant.188  Some 
experts estimate that approximately 1,000 organs are discarded each 
year because the time runs out before a suitable donor is found.189  
The United Network for Organ Sharing was expected to change its 
formulas in December 2014 to increase the utilization of donated 
kidneys and to reduce waste.190  As such, by finding a viable use for 
once discarded donations, especially those from elderly patients and 
“stale” organs, doctors may increase the supply of transplantable 
organs.191 
V. CONCLUSION 
There are thousands of people on the transplant list, and this 
number grows every day.  By increasing the supply of available 
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organs, more individuals may receive life-saving transplants.  The 
signing of the recent HOPE Act will hopefully make more organs 
available for HIV-positive recipients and thus result in more HIV-
negative organs available for HIV-negative individuals.  By changing 
the standards of organ donation from occurring after irreversible loss 
of brain function to irreversible loss of cardiac function, the organ 
supply may also increase.  While this suggestion has negative legal 
and ethical implications, the benefit may outweigh the negatives.  In 
addition, by educating individuals, especially minorities who have the 
greatest need for transplants, about donation and the regionally based 
system for transplants, more individuals may donate and also receive 
a greater chance of receiving a life-saving organ.  Finally, other 
measures, such as granting priority status to organ donors, allowing 
for the payment or solicitation of organs, and allowing age matching 
for donations, might increase the supply of organs available to be 
transplanted. 
 
